Found 49 articles
1/22/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team
miRagen Therapeutics, Inc. (NASDAQ: MGEN), a development-stage biotechnology company, today announced its name change to Viridian Therapeutics, Inc. (“Viridian”).
Recently completed acquisition of Viridian Therapeutics, including an anti-IGF-1R monoclonal antibody, VRDN-001, for the potential treatment of thyroid eye disease (TED) Private placement financing proceeds of approximately $91 million positions miRagen to potentially advance multiple compounds through Phase 2 proof of concept studies in TED and expand its orphan disease pipeline
Partnership with Huadong Medicine Accelerates Development and Commercialization of Mirvetuximab Soravtansine in Greater China Encouraging Anti-Tumor Activity and Tolerability Data from FORWARD II Triplet Cohort Evaluating Mirvetuximab in Combination with Carboplatin and Avastin ® in Platinum-Sensitive Ovarian Cancer Presented at ESMO FDA Breakthrough Therapy Designation Received for IMGN632 in Relapsed or Refractory BPDCN
Acquisition includes clinicalstage anti-IGF-1R monoclonal antibody, VRDN-001, intended for the treatment of thyroid eye disease (TED)
Transaction focused on the BOXR technology including lead program BOXR1030 Company fully focused on the development of small molecule precision kinase inhibitors to treat a range of genetically driven diseases Peter Harwin appointed as Board Chair
Quellis Biosciences Inc., an emerging biopharmaceutical company focused on discovering best-in-class new molecules to treat serious rare diseases, today announced its emergence from stealth operations and that it has closed a $17 million Series A financing led by the Perceptive Xontogeny Venture Fund (PXV Fund).
BR Brands, LLC ("BR Brands"), a consumer packaged goods ("CPG") company within the global legal cannabis industry, announced today that Mary's Brands™ co-founder and CEO, Lynn Honderd, has resigned as CEO and will partner with the organization as a strategic advisor.
New COO, a proven leader in agricultural science, also joins executive team
The number of cannabis users worldwide is tremendous, considering the number of countries that have yet to legalize it.
According to data provided by the European investment bank, Bryan, Garnier & Co., the legal global cannabis market is projected to grow more than 1,000% over the next decade and could reach USD 140 Billion by 2027.
CEO Craig Snyder will participate in a leadership panel presentation, “How Tech & Data are Shaping the Industry,” as part of the second annual State of the Cannabis Industry Conference to be held in Boston on October 4.
Trait Appoints International Marketing Executive, and former Diageo N.A. President & Chief Marketing Officer, Peter McDonough to Board of Directors
Trait Biosciences Inc. announced today that Peter J. McDonough, one of the world's leading consumer brand and marketing experts, has joined its Board of Directors, effective immediately.
Fusion Antibodies plc announces that it has been informed by Alan Mawson, a Non-Executive Director of the Company, that on 24 September 2018 he purchased 8,500 ordinary shares in the Company (“Ordinary Shares”) at a price of 67 pence per Ordinary Share via his personal pension scheme.
Digipath, Inc. is pleased to announce that Dr. Yunfeng Pan, PhD, has joined Digipath Labs as its Analytical Laboratory Director with oversight of analytical testing procedures.
According to the data provided by Energias Market Research, the global medical cannabis market is anticipated to increase in value from USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024
According to a report by Ameri Research Inc., the global legal cannabis market was valued at USD 14.3 Billion in 2016 and is projected to grow to USD 63.5 Billion by 2024
Digipath, Inc. is pleased to announce that Mr. Rene Adler has joined its Las Vegas laboratory as its Analytical Laboratory Manager with oversight of the ISO 17025:2017 quality management system.
North America leads the market holding nearly half of the market share in 2016.
According to a report by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is projected to grow at a CAGR of 21.1% between 2017 to 2024.